Table 4.
Comparison between patients with fully resolved versus partially reduced lymphadenopathy
| Variable | Outcome* | Mean (SD) | P-value |
|---|---|---|---|
| Short axis diameter (mm) | Fully resolved nodes | 6.4 (1.3) | 0.024† |
| Partially reduced nodes | 4.6 (0.9) | ||
| Vaccination to lymphadenopathy interval (days)‡ | Fully resolved nodes | 5.3 (3.3) | 0.728 |
| Partially reduced nodes | 6.2 (5.6) | ||
| Lymphadenopathy to referral interval (days) | Fully resolved nodes | 9 (8.9) | 0.001† |
| Partially reduced nodes | 35.6 (10.9) | ||
| Age (years) | Fully resolved nodes | 49.6 (16.2) | 0.106 |
| Partially reduced nodes | 65 (12.5) |
*Corresponding to subjective palpable swelling by patients. †Indicates statistical significance. ‡Reported by patients during telephone follow up. SD = standard deviation